Real-time enrollment status for this b-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:32 AM UTC
| NCT Number | NCT07223021 |
| Recruiting Status | Recruiting |
| Condition | B-cell Acute Lymphoblastic Leukemia |
| Phase | PHASE3 |
| Target Enrollment | 130 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT07223021 is currently recruiting participants. This phase3 study for b-cell acute lymphoblastic leukemia is actively seeking new participants at 5 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07223021 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07223021 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.